Silverfin false false 31/05/2025 31/05/2025 01/06/2024 no description of principal activity Mr Andrew Thomas Loughray 03/05/2024 Mrs Jean Louise Loughray 03/05/2024 15702154 2025-05-31 15702154 bus:Director1 2025-05-31 15702154 bus:Director2 2025-05-31 15702154 core:CurrentFinancialInstruments 2025-05-31 15702154 2024-06-01 2025-05-31 15702154 bus:Micro-entities 2024-06-01 2025-05-31 15702154 bus:FilletedAccounts 2024-06-01 2025-05-31 15702154 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 15702154 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 15702154 bus:Director1 2024-06-01 2025-05-31 15702154 bus:Director2 2024-06-01 2025-05-31 iso4217:GBP xbrli:pure

Company No: 15702154 (England and Wales)

# MEDILYNC LIMITED

### Unaudited Financial Statements
For the financial year ended 31 May 2025
Pages for filing with the registrar

MEDILYNC LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 May 2025

Contents

MEDILYNC LIMITED

## COMPANY INFORMATION

For the financial year ended 31 May 2025
MEDILYNC LIMITED

## COMPANY INFORMATION (continued)

For the financial year ended 31 May 2025

DIRECTORS | Mr Andrew Thomas Loughray
| Mrs Jean Louise Loughray

REGISTERED OFFICE | 73 Maycross Avenue
| Morden
| SM4 4DF
| United Kingdom

COMPANY NUMBER | 15702154 (England and Wales)

CHARTERED ACCOUNTANTS | Gascoynes
| Gascoyne House
| Moseleys Farm Business Centre
| Fornham All Saints
| Bury St Edmunds
| Suffolk
| IP28 6JY

MEDILYNC LIMITED

## BALANCE SHEET

As at 31 May 2025
MEDILYNC LIMITED

## BALANCE SHEET (continued)

For the financial year ended 31 May 2025

|  | 2025
|  | £
Current assets |  | 2,194
Creditors: amounts falling due within one year |  | ( 1,569)
Net current assets |  | 625
Total assets less current liabilities |  | 625
Accruals and deferred income |  | ( 1,536)
Net liabilities |  | ( 911)
Capital and reserves |  | ( 911)

For the financial year ending 31 May 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Medilync Limited (registered number: 15702154) were approved and authorised for issue by the Board of Directors on 07 October 2025 and were signed on its behalf by:

Mr Andrew Thomas Loughray Director |

MEDILYNC LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2025
MEDILYNC LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 May 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 15702154). The address of its registered office is 73 Maycross Avenue, Morden, SM4 4DF, United Kingdom.

#### 2. Employees

| 2025
| Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2